TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Aloe emodin, Gefitinib
Phytochemical Name Aloe emodin (PubChem CID: 10207 )
Anticancer drug Name Gefitinib (PubChem CID: 123631 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 303
Pair Name Aloe emodin, Gefitinib
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Inhibition-->Epithelial-mesenchymal transition
Gene Regulation Down-regulation Expression AKT1 hsa207
Down-regulation Expression PIK3CA hsa5290
Down-regulation Expression SLC22A3 hsa6581
In Vitro Model PC-9 Lung adenocarcinoma Homo sapiens (Human) CVCL_B260
PC-9-GR-high Lung adenocarcinoma Homo sapiens (Human) CVCL_S706
In Vivo Model After acclimated for one week, subcutaneous inoculation of 1×10⁷ PC9-GR cells was executed into the right flank of the animals (n = 4 in each group) to develop xenograft models.
Result AE could enhance the gefitinib sensitivity of PC9-GR cells and reverse EMT by blocking PI3K/Akt/TWIS1 signal pathway.
03. Reference
No. Title Href
1 Sensitization of Non-Small Cell Lung Cancer Cells to Gefitinib and Reversal of Epithelial-Mesenchymal Transition by Aloe-Emodin Via PI3K/Akt/TWIS1 Signal Blockage. Front Oncol. 2022 May 23;12:908031. doi: 10.3389/fonc.2022.908031. Click
It has been 48603 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP